SecBot SecBot

Medicaid VBPs for Patients Act

H.R. 2666 Rep. Brett Guthrie (R-KY-2) In committee
Bill text PDF
  1. Introduced Apr 18
  2. Committee Apr 18
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Apr 18, 2023Next: House vote
678d ago Dec 19, 2024: Placed on the Union Calendar, Calendar No. 768.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
9companies, 15 filings
Subscribe to see spend
Member trades
15trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

9 companies
Companies by sector
Biotech & Pharma 8Financials 1
Search all 9 companies, their asks and price moves Subscribe

Summary

Medicaid VBPs for Patients Act or the MVP Act

Full summary4 paragraphs

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.

Library of Congress summary, Apr 18, 2023

Summary versions
  • Introduced in HouseApr 18, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.